4//SEC Filing
Voermann Karsten 4
Accession 0001809519-24-000049
CIK 0001809519other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:12 PM ET
Size
8.4 KB
Accession
0001809519-24-000049
Insider Transaction Report
Form 4
Voermann Karsten
Chief Financial Officer
Transactions
- Award
Restricted Stock Unit
2024-03-12+357,168→ 357,168 total→ Class A Common Stock (357,168 underlying) - Award
Stock Option (Right to Buy)
2024-03-12+515,793→ 515,793 totalExercise: $7.22Exp: 2034-03-12→ Class A Common Stock (515,793 underlying)
Holdings
- 211,952
Class A Common Stock
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.
- [F3]The option will vest and become exercisable as to 25% of the underlying shares on January 8, 2025 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.
Documents
Issuer
GoodRx Holdings, Inc.
CIK 0001809519
Entity typeother
Related Parties
1- filerCIK 0001822140
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 5:12 PM ET
- Size
- 8.4 KB